simpleDigital Health Ecosystem MappingDigital HealthFunding

Europe Digital Health Innovation 2023 Year End Report

Galen Growth’s 2023 Europe Digital Health Innovation Year End Report is a fundamental resource, providing in-depth analysis for industry leaders, investors, and innovators. We focus our analysis on ecosystem key trends, through the lens of ecosystem growth, most active partners, regulatory approvals, key categories, therapeutic areas, venture funding, and more.

Europe Digital Health Innovation 2023 Year End Report

Europe's digital health ecosystem continues to evolve. While funding levels have declined, Europe remains a dynamic hub for Digital Health innovation. Ventures are focusing on evidence-based approaches, with a growing number leveraging AI and GenAI technologies to address healthcare challenges. In 2023, the Wellness cluster gained momentum, driven by high-profile deals and innovative solutions. Galen Growth is pleased to share with you our 2023 Year-End Report on Digital Health Key Trends in Europe. This report looks across the Digital Health startup ecosystem to reflect on the 2023 trends and move the industry forward into 2024. Our analysis focuses on private ventures and includes most active partners, regulatory approvals and venture funding strength, among others. HealthTech Alpha, a Galen Growth proprietary solution, and the world’s leading Digital Health private market data, intel and insights platform powers this report!

Highlights from the 2023 Europe Digital Health Innovation Report

Despite Global Funding Downturn, Europe Remains a Hotbed for Digital Health Investments

  • 2023 witnessed a 42% YoY decline in Digital Health venture funding in Europe, mirroring global trends.
  • Germany and Switzerland bucked the trend, with venture capital investments exceeding 2022 levels.
  • Europe has surpassed Asia Pacific to become the second-largest market for Digital Health venture capital investments.

Digital Health Ventures Face Funding Challenges, But Europe Leads in Evidence-Based Approaches

  • Despite funding reductions, Europe maintains a similar funding landscape to North America, with 43% of growth-stage ventures securing funding within the typical runway period.
  • Europe's Digital Health ecosystem stands out globally, with 30% of ventures achieving a high Evidence Signal, indicating robust clinical trials, regulatory approvals, or peer-reviewed publications.

AI Adoption Gains Traction, Wellness Cluster Outperforms

  • AI and Generative AI (GenAI) technologies are gaining traction in Europe, with 42% of private Digital Health ventures adopting these advancements.
  • AI adoption is particularly prevalent in Medical Diagnostics and Patient Solutions, with 45% of ventures specializing in these areas utilizing AI or GenAI.
  • GenAI technology is gaining prominence in research-focused ventures, with 8% of Research Solutions Cluster companies employing this advanced AI approach.
  • The Wellness cluster emerged as the top-funded Digital Health sector in 2023, attracting $415M, driven by mega deals from eGym and Urban Sports Club.

Ventures and Companies Covered in the Report

The “2023 Europe Digital Health Innovation Year End Report” includes data on the following companies:
Charac, Dawn Health, Exscientia, Huma, Owkin, eGym, CMR Surgical, Volta Medical, Distalmotion, Alentis Therapeutics, Peppy, Urban Sports Club, Quell, Clinomic, Cyted, Causaly, Crescendo Biologics, BioSerenity, LUMA Vision, Patient21, Diamond Whites, Babylon Health, aidhere, Medexprim, 7Mind, PrecisionLife, Deepc, CliniNote, Quibim, Impress, eMed, Gymondo, Oura, NHS, Novartis, Merck, Merck KGaA, Servier, BC Platforms, Absci, BT Health, Philips, Affinity Partners, Softbank, Ally Bridge Group, Escala Capital, Revival Healthcare Capital, Pitango Venture Capital, Verdane Capital

Delve into the Digital Health Innovation 2023 Year End Reports for Asia Pacific and North America

Get the report

Use your company email address. Personal and disposable email services are not accepted.